DexCom, Inc. (DXCM)
USD 61.8
(-9.3%)
USD 61.8
(-9.3%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 916.7 Million USD | 119.88% |
| 2022 | 565.3 Million USD | 50.29% |
| 2021 | 377.5 Million USD | -27.52% |
| 2020 | 376.8 Million USD | 132.64% |
| 2019 | 213.2 Million USD | 258.48% |
| 2018 | -74.7 Million USD | -189.94% |
| 2017 | -19.7 Million USD | 44.24% |
| 2016 | -49.2 Million USD | -12.43% |
| 2015 | -46.3 Million USD | -165.58% |
| 2014 | -13.1 Million USD | 1.83% |
| 2013 | -21.9 Million USD | 55.31% |
| 2012 | -49 Million USD | -19.26% |
| 2011 | -40.97 Million USD | -19.34% |
| 2010 | -51.18 Million USD | 20.79% |
| 2009 | -43.1 Million USD | 11.81% |
| 2008 | -49.79 Million USD | -13.69% |
| 2007 | -43.34 Million USD | 7.03% |
| 2006 | -46.62 Million USD | -48.65% |
| 2005 | -29.7 Million USD | -138.85% |
| 2004 | -13.13 Million USD | -33.57% |
| 2003 | -9.83 Million USD | -55.78% |
| 2002 | -6.31 Million USD | 6.14% |
| 2001 | -6.72 Million USD | -67.51% |
| 2000 | -4.01 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 210.1 Million USD | 29.06% |
| 2024 Q3 | 237.4 Million USD | -2.98% |
| 2024 Q1 | 189.6 Million USD | -37.55% |
| 2023 Q4 | 303.6 Million USD | 46.53% |
| 2023 Q1 | 110.7 Million USD | -20.76% |
| 2023 Q2 | 166.9 Million USD | 50.77% |
| 2023 Q3 | 207.2 Million USD | 24.15% |
| 2023 FY | - USD | 119.88% |
| 2022 Q4 | 139.7 Million USD | -26.47% |
| 2022 FY | - USD | 50.29% |
| 2022 Q1 | 78.3 Million USD | 541.8% |
| 2022 Q2 | 123.6 Million USD | 57.85% |
| 2022 Q3 | 190 Million USD | 53.72% |
| 2021 Q2 | 125.4 Million USD | 87.44% |
| 2021 Q3 | 142.1 Million USD | 13.32% |
| 2021 Q1 | 66.9 Million USD | -47.03% |
| 2021 FY | - USD | -27.52% |
| 2021 Q4 | 12.2 Million USD | -91.41% |
| 2020 Q4 | 126.3 Million USD | 6.67% |
| 2020 Q1 | 50.8 Million USD | -53.65% |
| 2020 Q3 | 118.4 Million USD | 64.67% |
| 2020 FY | - USD | 132.64% |
| 2020 Q2 | 71.9 Million USD | 41.54% |
| 2019 Q2 | 5.7 Million USD | 416.67% |
| 2019 FY | - USD | 258.48% |
| 2019 Q4 | 109.6 Million USD | 48.51% |
| 2019 Q1 | -1.8 Million USD | 98.93% |
| 2019 Q3 | 73.8 Million USD | 1194.74% |
| 2018 FY | - USD | -189.94% |
| 2018 Q1 | -19.2 Million USD | -244.36% |
| 2018 Q2 | 41.1 Million USD | 314.06% |
| 2018 Q3 | 57.5 Million USD | 39.9% |
| 2018 Q4 | -168.7 Million USD | -393.39% |
| 2017 Q2 | -7.4 Million USD | 79.5% |
| 2017 Q3 | 6.3 Million USD | 185.14% |
| 2017 FY | - USD | 44.24% |
| 2017 Q4 | 13.3 Million USD | 111.11% |
| 2017 Q1 | -36.1 Million USD | -438.81% |
| 2016 Q3 | -14.3 Million USD | 11.18% |
| 2016 Q2 | -16.1 Million USD | -2.55% |
| 2016 Q4 | -6.7 Million USD | 53.15% |
| 2016 FY | - USD | -12.43% |
| 2016 Q1 | -15.7 Million USD | -1081.25% |
| 2015 FY | - USD | -165.58% |
| 2015 Q4 | 1.6 Million USD | 104.03% |
| 2015 Q3 | -39.7 Million USD | -3870.0% |
| 2015 Q2 | -1 Million USD | 92.13% |
| 2015 Q1 | -12.7 Million USD | -893.75% |
| 2014 Q3 | -2.8 Million USD | 28.21% |
| 2014 Q4 | 1.6 Million USD | 157.14% |
| 2014 FY | - USD | 1.83% |
| 2014 Q1 | -10.4 Million USD | -2500.0% |
| 2014 Q2 | -3.9 Million USD | 62.5% |
| 2013 FY | - USD | 55.31% |
| 2013 Q4 | -400 Thousand USD | 90.24% |
| 2013 Q2 | -8.3 Million USD | 8.79% |
| 2013 Q1 | -9.1 Million USD | -39.02% |
| 2013 Q3 | -4.1 Million USD | 50.6% |
| 2012 Q3 | -15.1 Million USD | -14.8% |
| 2012 Q2 | -13.15 Million USD | 7.27% |
| 2012 Q1 | -14.19 Million USD | -26.54% |
| 2012 FY | - USD | -19.26% |
| 2012 Q4 | -6.54 Million USD | 56.67% |
| 2011 Q4 | -11.21 Million USD | 8.9% |
| 2011 Q3 | -12.31 Million USD | -89.47% |
| 2011 Q2 | -6.49 Million USD | 41.28% |
| 2011 Q1 | -11.06 Million USD | -19.93% |
| 2011 FY | - USD | -19.34% |
| 2010 Q2 | -10.43 Million USD | -294.67% |
| 2010 Q1 | -2.64 Million USD | 70.6% |
| 2010 Q4 | -9.22 Million USD | 23.9% |
| 2010 Q3 | -12.12 Million USD | -16.17% |
| 2010 FY | - USD | 20.79% |
| 2009 Q3 | -10.99 Million USD | 18.32% |
| 2009 FY | - USD | 11.81% |
| 2009 Q4 | -8.99 Million USD | 18.18% |
| 2009 Q2 | -13.45 Million USD | -25.92% |
| 2009 Q1 | -10.68 Million USD | 9.72% |
| 2008 Q4 | -11.83 Million USD | 9.94% |
| 2008 FY | - USD | -13.69% |
| 2008 Q2 | -12.61 Million USD | -8.3% |
| 2008 Q1 | -11.65 Million USD | -5.58% |
| 2008 Q3 | -13.14 Million USD | -4.16% |
| 2007 Q1 | -10.83 Million USD | -1.35% |
| 2007 Q2 | -10.75 Million USD | 0.74% |
| 2007 Q3 | -10.73 Million USD | 0.19% |
| 2007 Q4 | -11.03 Million USD | -2.83% |
| 2007 FY | - USD | 7.03% |
| 2006 Q4 | -10.68 Million USD | 21.76% |
| 2006 FY | - USD | -48.65% |
| 2006 Q3 | -13.65 Million USD | -14.71% |
| 2006 Q2 | -11.9 Million USD | -23.58% |
| 2006 Q1 | -9.63 Million USD | 21.07% |
| 2005 Q1 | -5.39 Million USD | 0.0% |
| 2005 Q4 | -12.2 Million USD | -77.89% |
| 2005 Q3 | -6.86 Million USD | -10.1% |
| 2005 Q2 | -6.23 Million USD | -15.55% |
| 2005 FY | - USD | -138.85% |
| 2004 FY | - USD | -33.57% |
| 2003 FY | - USD | -55.78% |
| 2002 FY | - USD | 6.14% |
| 2001 FY | - USD | -67.51% |
| 2000 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 6896.916% |
| Cerus Corporation | -26.53 Million USD | 3554.552% |
| OrthoPediatrics Corp. | -8.38 Million USD | 11037.836% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 8835.06% |
| Talis Biomedical Corporation | -66.04 Million USD | 1487.993% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 5597.451% |
| Inogen, Inc. | -45.67 Million USD | 2106.83% |
| Spectral AI, Inc. | -12.26 Million USD | 7575.942% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 2022.085% |
| CVRx, Inc. | -38.73 Million USD | 2466.838% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 26083.56% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 7671.653% |
| Orthofix Medical Inc. | -86.98 Million USD | 1153.86% |
| Venus Concept Inc. | -26.11 Million USD | 3610.512% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 1941.836% |
| Bioventus Inc. | -23.07 Million USD | 4073.559% |
| BrainsWay Ltd. | -2.31 Million USD | 39766.811% |
| Envoy Medical, Inc. | -18.23 Million USD | 5126.319% |
| electroCore, Inc. | -17.76 Million USD | 5261.599% |
| IceCure Medical Ltd | -15.25 Million USD | 6109.965% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 1942.576% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 5538.518% |
| MaxCyte, Inc. | -44.12 Million USD | 2177.366% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 7897.731% |
| Nexalin Technology, Inc. | -5.69 Million USD | 16204.941% |
| PAVmed Inc | -75.74 Million USD | 1310.293% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 1805.235% |
| RxSight, Inc. | -41.03 Million USD | 2333.838% |
| Sight Sciences, Inc. | -49.41 Million USD | 1955.105% |
| SI-BONE, Inc. | -34.44 Million USD | 2761.267% |
| TELA Bio, Inc. | -40.63 Million USD | 2356.048% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 1672.438% |
| Treace Medical Concepts, Inc. | -39 Million USD | 2450.031% |
| LivaNova PLC | 39.01 Million USD | -2249.549% |
| 908 Devices Inc. | -34.02 Million USD | 2794.195% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 928.903% |
| Nemaura Medical Inc. | -7.28 Million USD | 12679.838% |
| NeuroPace, Inc. | -22.83 Million USD | 4114.627% |
| LENSAR, Inc. | -8.71 Million USD | 10619.853% |
| Apyx Medical Corporation | -18.11 Million USD | 5161.285% |
| Cutera, Inc. | -136.56 Million USD | 771.275% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 27221.302% |
| BioSig Technologies, Inc. | -28.15 Million USD | 3356.367% |
| Anika Therapeutics, Inc. | 2.51 Million USD | -36334.817% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 4467.526% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | -138.992% |
| Axonics, Inc. | 7.77 Million USD | -11690.354% |
| Outset Medical, Inc. | -153.78 Million USD | 696.076% |
| IRIDEX Corporation | -7.44 Million USD | 12408.002% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 1034.502% |
| IRadimed Corporation | 20.8 Million USD | -4307.076% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 11470.629% |
| INVO Bioscience, Inc. | -6.88 Million USD | 13424.083% |
| Telesis Bio, Inc. | -40.49 Million USD | 2363.848% |
| Viemed Healthcare, Inc. | 36.67 Million USD | -2399.387% |
| Varex Imaging Corporation | 67.2 Million USD | -1264.137% |
| Quipt Home Medical Corp. | 44.07 Million USD | -1980.053% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 8533.303% |
| Pulmonx Corporation | -55.09 Million USD | 1763.944% |
| Dynatronics Corporation | -976 Thousand USD | 94023.41% |
| Modular Medical, Inc. | -17.1 Million USD | 5459.878% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 6428.616% |
| Semler Scientific, Inc. | 23.58 Million USD | -3786.133% |
| InMode Ltd. | 196.28 Million USD | -367.03% |
| Bruker Corporation | 599 Million USD | -53.038% |
| Cytosorbents Corporation | -28.81 Million USD | 3281.791% |
| Align Technology, Inc. | 799.03 Million USD | -14.725% |
| Viveve Medical, Inc. | -20.61 Million USD | 4546.331% |
| ZimVie Inc. | 91.07 Million USD | -906.555% |
| Movano Inc. | -29.12 Million USD | 3247.468% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 20896.284% |
| Nexalin Technology, Inc. | -5.69 Million USD | 16204.941% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 26083.56% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 570.931% |
| Profound Medical Corp. | -27.12 Million USD | 3479.732% |
| Insulet Corporation | 323.6 Million USD | -183.282% |
| enVVeno Medical Corporation | -25.01 Million USD | 3764.162% |
| Surmodics, Inc. | 1.18 Million USD | -77063.3% |
| iCAD, Inc. | -6.56 Million USD | 14063.442% |
| Nuwellis, Inc. | -16.35 Million USD | 5704.671% |
| Biotricity, Inc. | -8.82 Million USD | 10483.689% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 1046.398% |
| Aethlon Medical, Inc. | -11.84 Million USD | 7836.441% |
| InspireMD, Inc. | -20.91 Million USD | 4483.817% |
| PAVmed Inc. | -75.74 Million USD | 1310.293% |
| BIOLASE, Inc. | -15.13 Million USD | 6155.222% |
| Beyond Air, Inc. | -59.03 Million USD | 1652.913% |
| FONAR Corporation | 28.25 Million USD | -3144.776% |
| AxoGen, Inc. | -13.32 Million USD | 6978.001% |
| Vivani Medical, Inc. | -26.6 Million USD | 3545.204% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | -3635.382% |
| Inari Medical, Inc. | 7.11 Million USD | -12787.67% |
| UFP Technologies, Inc. | 72.74 Million USD | -1160.19% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 27174.954% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 14991.175% |
| Tenon Medical, Inc. | -15.52 Million USD | 6003.529% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 6104.847% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 2310.207% |
| AdaptHealth Corp. | -171.09 Million USD | 635.797% |
| Sintx Technologies, Inc. | -6.6 Million USD | 13989.394% |
| NanoVibronix, Inc. | -3.43 Million USD | 26787.045% |
| Quanterix Corporation | -38.08 Million USD | 2506.795% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 8533.303% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -3055566.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 430.602% |
| TransMedics Group, Inc. | -7.6 Million USD | 12157.083% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 4311.808% |
| NeuroMetrix, Inc. | -7.09 Million USD | 13018.893% |
| Hyperfine, Inc. | -47.06 Million USD | 2047.897% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 1672.195% |
| Biomerica, Inc. | -5.99 Million USD | 15396.179% |
| Bone Biologics Corporation | 479.57 Thousand USD | -191049.608% |
| AVITA Medical, Inc. | -39.56 Million USD | 2416.785% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 10093.533% |
| Silk Road Medical, Inc | -45.08 Million USD | 2133.496% |